HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

alpha-2-Adrenergic activation of proopiomelanocortin-containing neurons in the arcuate nucleus causes opioid-mediated hypotension and bradycardia.

Abstract
Treatment of rats for 4 days with alpha-methyldopa, 200 mg/kg/day i.p., increases steady state levels of proopiomelanocortin (POMC) mRNA in the mediobasal hypothalamus, as measured by DNA excess solution hybridization. The increase is prevented by parallel treatment with yohimbine, 2 mg/kg/day i.p., but not by naltrexone, 2 mg/kg/day i.p. Treatment with the peripheral vasodilator hydralazine, 2 mg/kg/day, does not affect POMC mRNA levels. In situ hybridization histochemistry with a cRNA probe for POMC indicates that POMC-containing cells are located within the confines of the arcuate nucleus both in control and in alpha-methyldopa-treated rats, and confirms the increase in POMC mRNA in the latter. Microinjection of 2 micrograms of alpha-methylnorepinephrine unilaterally into the arcuate nucleus of urethane-anesthetized rats causes hypotension and bradycardia, which can be inhibited by 200 ng of yohimbine microinjected into the same site, or by 100 ng l-naloxone microinjected into the ipsilateral nucleus tractus solitarii, but not into the arcuate nucleus. These findings are interpreted to indicate that activation of alpha 2-adrenergic receptors located on POMC-containing neurons in the arcuate nucleus causes beta-endorphin release and stimulation of opiate receptors in the NTS, which results in hypotension and bradycardia, and that this mechanism contributes to the hypotensive action of alpha-methyldopa.
AuthorsS J Li, M N Scanlon, Z Járai, K Varga, N S Gantenberg, E Lazar-Wesley, G Kunos
JournalNeuroendocrinology (Neuroendocrinology) Vol. 63 Issue 3 Pg. 275-83 (Mar 1996) ISSN: 0028-3835 [Print] SWITZERLAND
PMID8677016 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adrenergic alpha-Agonists
  • RNA, Messenger
  • Receptors, Adrenergic, alpha
  • Yohimbine
  • Methyldopa
  • beta-Endorphin
  • Pro-Opiomelanocortin
  • Nordefrin
Topics
  • Adrenergic alpha-Agonists (administration & dosage, pharmacology)
  • Animals
  • Arcuate Nucleus of Hypothalamus (drug effects, physiopathology)
  • Bradycardia (chemically induced, physiopathology)
  • Hypotension (chemically induced, physiopathology)
  • In Situ Hybridization
  • Male
  • Methyldopa (pharmacology)
  • Microinjections
  • Neurons (physiology)
  • Nordefrin (administration & dosage, pharmacology)
  • Pro-Opiomelanocortin (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha (drug effects, physiology)
  • Yohimbine (pharmacology)
  • beta-Endorphin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: